/
Thyroid Cancer Survival – Population based study – EUROCARE-5 Thyroid Cancer Survival – Population based study – EUROCARE-5

Thyroid Cancer Survival – Population based study – EUROCARE-5 - PowerPoint Presentation

Princecharming
Princecharming . @Princecharming
Follow
342 views
Uploaded On 2022-07-28

Thyroid Cancer Survival – Population based study – EUROCARE-5 - PPT Presentation

Dr Dominic Agius Head Malta National Cancer Registry 20 th October 2017 ID: 930417

thyroid survival results cancer survival thyroid cancer results women relative men incidence papillary period type age rates trends histology

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Thyroid Cancer Survival – Population b..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Thyroid Cancer Survival – Population based study – EUROCARE-5

Dr Dominic Agius

Head Malta National Cancer Registry

20

th

October, 2017

Slide2

Overview

Over last 25 years:

Relative survival from thyroid cancer by sex, country, age, period and histological type

Thyroid cancer incidence – increased

Mortality trends – stable

Slide3

Methods

Data from 29 countries

1.One and five year Relative Survival Rates for adult patients diagnosed in 2000-2007 and followed-up till end of 2008

2. Trends in Relative Survival Rates in1999-2007 period

3. 10-year Relative Survival Rates in 2005-2007

Slide4

Results (incidence)

Overall 5-yr Relative Survival

Women – 88%; Men – 81%

Strong correlation by country between

survival

and

incidence rates and histological type

:

Highest incidence, survival, papillary type (79%) in Southern Europe.

Lowest in UK and Ireland – papillary type (58%);

Follicular type (23% - 15% in Europe)

Slide5

Results (incidence cont.)

Thyroid cancer: Survival – Incidence

Females

Slide6

Results (incidence cont.)

Thyroid cancer: Survival – Incidence

Men

Slide7

Results (Histology)

5-yr Relative Survival vs histology

Papillary (98% in woman; 94% in men)

Follicular (92% in women; 87% in men)

Medullary (88% in women; 75% in men)

Anaplastic (14% in women; 12% in men)

Slide8

Results (Histology)

5-yr RS for papillary thyroid cancer by period and region - women

Slide9

Results (Histology)

5-yr RS for follicular thyroid cancer by period and region – women

Slide10

Results (Age)

Thyroid cancer: 5-yr RS by age

Age (

yr

)

Women

Men

15-44

>99%

97%

45-54

>95%

90%

55-64

93%

84%

65-74

82%

70%

75+

57%

51%

Slide11

Results – 10-yr RS

Ten-year relative survival (10-yr RS, %), and 10-year relative survival conditional on surviving five years (10-yr/5-yr)

10-yr RS %

10-yr RS conditional on surviving 5 yrs

Women

89.4 (88.6-90)

97.5 (96-99)

Men

79.2 (77.5-80.7)

94.6 (90.9-98.5)

Slide12

Thyroid cancer survival trends

5-yr RS over period 1999-2007

All thyroid cancers +5%

Papillary thyroid cancer +2%

Follicular thyroid cancer +4%

In women only, medullary and anaplastic cancers +7%

Slide13

Conclusions

Trends in thyroid cancer survival and country differences seem to be explained by:

Varying histological case-mix

Age distribution of cases

Results could inform management strategies aimed at reducing unnecessary and harmful treatments that negatively impinge on patients’ quality of life

Slide14

Thank you